B. Riley raised the firm’s price target on Imax to $30 from $27 and keeps a Buy rating on the shares ahead of the Q2 report. The analyst reduced estimates, saying the Q2 domestic industry box office missed expectations. However, post-pandemic moviegoers continue to flock to premium screens, the analyst tells investors in a research note.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAX: